List Biological Laboratories, Inc.
Nuria Gonzalez Montalban, PhD, currently serves as the Director of Biologics Development at List Biological Laboratories, Inc. since July 2022. Previously, Nuria held roles as Quality Control Manager in Microbiology and Support, as well as Senior Scientist in Method Development and Validation at Bachem from July 2020 to June 2022. Experience also includes a position as Senior Scientist at Trace-Ability, Inc. focusing on assay development and validation for radio-pharmaceuticals from August 2016 to June 2020. Prior to that, Nuria was Operations Manager at For Goodness Cakes in California and served as a postdoctoral fellow at the University of Maryland School of Medicine, participating in NIH xTrain and achieving four peer-reviewed publications related to prion conversion and molecular mechanisms of viral infections. Educational credentials include a PhD in Biotechnology and Microbiology from Universitat Autònoma de Barcelona, complemented by a Master's degree and a Bachelor's degree in Microbiology from the same institution.
This person is not in any teams
List Biological Laboratories, Inc.
List Labs specializes in the production of native toxins, recombinant proteins, bacterial fermentation, assay development, contract manufacturing, and biotherapeutics. List Labs produces C. difficile toxin A and toxin B, shiga toxins, cholera toxin, anthrax toxins (PA, LF, and EF), pertussis toxin, diphtheria toxin, CRM197, tetanus toxin, staphylococcal enterotoxin B, botulinum toxins as well as several types of lipopolysaccharides (LPS) or endotoxin for purchase by the research community.